358 related articles for article (PubMed ID: 32622952)
1. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
Tan C; Huang Y; Shi F; Tan K; Ma Q; Chen Y; Jiang X; Li X
J Med Virol; 2020 Jul; 92(7):856-862. PubMed ID: 32281668
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.
Yang AP; Liu JP; Tao WQ; Li HM
Int Immunopharmacol; 2020 Jul; 84():106504. PubMed ID: 32304994
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
5. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory features of COVID-19: Predictors of severe prognosis.
Bastug A; Bodur H; Erdogan S; Gokcinar D; Kazancioglu S; Kosovali BD; Ozbay BO; Gok G; Turan IO; Yilmaz G; Gonen CC; Yilmaz FM
Int Immunopharmacol; 2020 Nov; 88():106950. PubMed ID: 32919217
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
[TBL] [Abstract][Full Text] [Related]
8. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
[No Abstract] [Full Text] [Related]
10. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
[No Abstract] [Full Text] [Related]
11. Clinical features and treatment of COVID-19 patients in northeast Chongqing.
Wan S; Xiang Y; Fang W; Zheng Y; Li B; Hu Y; Lang C; Huang D; Sun Q; Xiong Y; Huang X; Lv J; Luo Y; Shen L; Yang H; Huang G; Yang R
J Med Virol; 2020 Jul; 92(7):797-806. PubMed ID: 32198776
[TBL] [Abstract][Full Text] [Related]
12. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].
Fei M; Tong F; Tao X; Wang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346
[TBL] [Abstract][Full Text] [Related]
13. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
[TBL] [Abstract][Full Text] [Related]
14. Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time.
Davido B; Boussaid G; Vaugier I; Lansaman T; Bouchand F; Lawrence C; Alvarez JC; Moine P; Perronne V; Barbot F; Saleh-Mghir A; Perronne C; Annane D; De Truchis P;
Int J Antimicrob Agents; 2020 Oct; 56(4):106129. PubMed ID: 32755653
[TBL] [Abstract][Full Text] [Related]
15. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
16. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of serum amyloid A in patients with COVID-19.
Cheng L; Yang JZ; Bai WH; Li ZY; Sun LF; Yan JJ; Zhou CL; Tang BP
Infection; 2020 Oct; 48(5):715-722. PubMed ID: 32734556
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
[No Abstract] [Full Text] [Related]
19. Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19.
Pakos IS; Lo KB; Salacup G; Pelayo J; Bhargav R; Peterson E; Gul F; DeJoy R; Albano J; Patarroyo-Aponte G; Rangaswami J; Azmaiparashvili Z
Eur J Haematol; 2020 Dec; 105(6):773-778. PubMed ID: 32794205
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19.
Wang H; Zhang Y; Mo P; Liu J; Wang H; Wang F; Zhao Q
Int Immunopharmacol; 2020 Aug; 85():106683. PubMed ID: 32531713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
